rHIgM22 / Acorda, Mayo Clinic  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rHIgM22 / Acorda
M22, NCT01803867: An Intravenous Infusion Study of rHIg in Patients With Multiple Sclerosis

Completed
1
72
US
rHIgM22, M22
Acorda Therapeutics, PRA Health Sciences
Multiple Sclerosis
10/14
01/15
NCT02398461: An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse

Completed
1
27
US
rHIgM22, M22, Placebo
Acorda Therapeutics, PRA Health Sciences
Multiple Sclerosis, Acute Relapsing
09/17
09/17

Download Options